These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 370820

  • 21. Efficiency of short-course tuberculosis chemotherapy in controlled clinical trials and in programme conditions in Romania.
    Anastasatu C, Corlan E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):133-9. PubMed ID: 2999949
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative evaluation of tuberculosis therapy regimens in treating patients with destructive pulmonary tuberculosis].
    Berezovskiĭ BA, Marchak VV, Shepetovskaia TA, Zaĭkov SV, Nagornaia EG.
    Probl Tuberk; 1985; (10):28-30. PubMed ID: 4070200
    [No Abstract] [Full Text] [Related]

  • 23. Modern short-course regimens in the treatment of tuberculosis.
    Fox W.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract] [Full Text] [Related]

  • 24. [Successes and failures in the treatment of tuberculosis].
    Lukas W.
    Z Allgemeinmed; 1972 Sep 10; 48(25):1127-31. PubMed ID: 5083372
    [No Abstract] [Full Text] [Related]

  • 25. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E, Polaczek E, Araszkiewicz W, Kozakow H, Pszonicka A, Styszewska H, Janowiec M, Grabowska R.
    Gruzlica; 1973 Jul 10; 41(7):781-7. PubMed ID: 4730979
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment effectiveness in newly detected destructive pulmonary tuberculosis using different combinations of chemical preparations].
    Pospelov VV, Pashkov IuN.
    Probl Tuberk; 1982 Mar 10; (3):38-40. PubMed ID: 7088921
    [No Abstract] [Full Text] [Related]

  • 27. [The efficacy of 6 months' chemotherapy of newly diagnosed patients with pulmonary tuberculosis].
    Gamperis Iu, Gaĭdamonene D, Dimbelene M, Pavlitska L, Nevirovska Z.
    Probl Tuberk; 1990 Mar 10; (6):60-1. PubMed ID: 2217108
    [No Abstract] [Full Text] [Related]

  • 28. [Results and aspects of the use of regimens of short-term antitubercular chemotherapy (3+3) in a program of the Cluj County region].
    Petrescu G, Gloabă L.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988 Mar 10; 37(3):237-47. PubMed ID: 2855669
    [No Abstract] [Full Text] [Related]

  • 29. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V, Mijatović M, Mirković S, Muzikravić T.
    Plucne Bolesti Tuberk; 1972 Mar 10; 24(2):89-98. PubMed ID: 4565191
    [No Abstract] [Full Text] [Related]

  • 30. [Characteristics of newly detected destructive forms of pulmonary tuberculosis].
    Litvin LM, Rybak IuN, Ladnyĭ AIa, Nemesh AA, Sirko AV.
    Vrach Delo; 1981 May 10; (5):25-6. PubMed ID: 7257255
    [No Abstract] [Full Text] [Related]

  • 31. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG, Cramer G, Götz J, Holzhauer H, Niegsch G, Sieler H, Velten G, Völker L.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 May 10; 138(1):107-15. PubMed ID: 4203235
    [No Abstract] [Full Text] [Related]

  • 32. [Operational aspects in the implementation of short-term antituberculous treatment].
    Pacheco CR.
    Salud Publica Mex; 1985 May 10; 27(1):31-9. PubMed ID: 3992356
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of short-course chemotherapy in Romania.
    Anastasatu C.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985 May 10; 34(2):178-81. PubMed ID: 2999961
    [No Abstract] [Full Text] [Related]

  • 34. [Controlled clinical study on the tolerance of feprazone in pulmonary tuberculosis].
    Giraldi N, Corti G, Montanari C.
    Clin Ter; 1976 May 31; 77(4):317-27. PubMed ID: 795588
    [No Abstract] [Full Text] [Related]

  • 35. [Short-term chemotherapy. Controlled clinical trials in Chile].
    Farga V, Valenzuela P, Mendoza F, Torres E, Icekson I, Grinspun M, Fernández M, Corradini A, Martínez M, Velasco J.
    Bull Int Union Tuberc; 1983 Jun 31; 58(2):102-7. PubMed ID: 6360261
    [No Abstract] [Full Text] [Related]

  • 36. [The effect of short-term treatment on the evolution toward chronicity of pulmonary tuberculosis].
    Basacopol A, Alexandrescu D, Stanciu M.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989 Jun 31; 38(2):177-9. PubMed ID: 2555905
    [No Abstract] [Full Text] [Related]

  • 37. [Chemo-tuberculinotherapy in combination with tissue electrophoresis in treating newly detected destructive pulmonary tuberculosis].
    Il'nitskiĭ IG.
    Vrach Delo; 1982 Nov 31; (11):59-61. PubMed ID: 7157762
    [No Abstract] [Full Text] [Related]

  • 38. [Effectiveness of the chemotuberculinotherapy of patients with destructive pulmonary tuberculosis].
    Il'nitskiĭ IG.
    Probl Tuberk; 1985 Nov 31; (4):36-8. PubMed ID: 4001106
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of patients with pulmonary tuberculosis with antitubercular preparations and levamisole].
    Feuereisl R, Papezová E.
    Probl Tuberk; 1988 Nov 31; (3):31-3. PubMed ID: 3290887
    [No Abstract] [Full Text] [Related]

  • 40. [Methods of evaluation of the effectiveness of chemotherapy of patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG, Stadnikova AV, Biazrov TA.
    Probl Tuberk; 1974 Mar 31; 52(3):6-12. PubMed ID: 4828056
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.